logo
Select company
Select metric
$ -5.09MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
29
Sector
68
Industry
85
History
96
$ 1.05Close
$ 0.75 - $ 1.97 52-Week Range
Ticker Information

Ticker

DYAI

Company Name

DYADIC INTERNATIONAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

DYADIC INTERNATIONAL INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DYAI - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 0$ -5.09M$ -5.09M
3/31/2025$ 0$ -5.32M$ -5.32M
12/31/2024$ 0$ -5.38M$ -5.38M
9/30/2024$ 0$ -6.03M$ -6.03M
6/30/2024$ 0$ -7.57M$ -7.57M
3/31/2024$ 0$ -7.82M$ -7.82M
12/31/2023$ 0$ -6.8M$ -6.8M
9/30/2023$ 0$ -6.87M$ -6.87M
6/30/2023$ 0$ -7.07M$ -7.07M
3/31/2023$ 0$ -8.2M$ -8.2M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • DYADIC INTERNATIONAL INC's latest trailing twelve months (TTM) EBITDA stands at $ -9.09M.
  • Over the past 5 years, DYADIC INTERNATIONAL INC's average EBITDA has been $ -8.79M.
  • The median EBITDA for DYADIC INTERNATIONAL INC during this period was $ -8.65M
  • DYADIC INTERNATIONAL INC reached its highest EBITDA over the past 5 years at $ -5.09M.
  • The lowest EBITDA recorded by DYADIC INTERNATIONAL INC in the same timeframe $ -13.07M

DYADIC INTERNATIONAL INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CAMP : CAMP4 THERAPEUTICS CORP $ -48.23MNRXS : NEURAXIS INC $ -7.03MLPCN : LIPOCINE INC $ -4.45MBOLT : BOLT BIOTHERAPEUTICS INC $ -47.13MSTTK : SHATTUCK LABS INC $ -57.29MCLSD : CLEARSIDE BIOMEDICAL INC $ -26.67MMRKR : MARKER THERAPEUTICS INC $ -14.56MIGC : IGC PHARMA INC $ -5.75MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.31MALGS : ALIGOS THERAPEUTICS INC $ -58.76M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for DYADIC INTERNATIONAL INC is calculated as follows: EBIT [ $ -9.09M ] + DepAmor [ $ 0 ]
(=) EBITDA [ $ -9.09M ]

DYAI - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -13.07M

Minimum

Dec 31, 2021

$ -5.09M

Maximum

Jun 30, 2025

$ -8.79M

Average

$ -8.65M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M